Detection and characterization of antibodies to PEG-IFN-α2b using surface plasmon resonance

Journal of Interferon and Cytokine Research

Volumn 19, Issue 7, 1999, Pages 781-789

  Takacs, Melisa A ^a   Jacobs, Sheila J ^a   Bordens, Ronald M ^a   Swanson, Steven J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; INTERFERON ANTIBODY; MACROGOL;

ACCURACY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMOBILIZATION; MICROPROCESSOR; PRIORITY JOURNAL; RELIABILITY; SENSOR; SURFACE PLASMON RESONANCE;

ANTIBODY SPECIFICITY; ANTIVIRAL AGENTS; HUMANS; IMMUNOGLOBULIN ISOTYPES; INTERFERON ALFA-2A; POLYETHYLENE GLYCOLS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 0032811519     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313631     Document Type: Article

References (21)

1. DAVIS, G.L., BALART, L.A., SCHIFF, E.R., LINDSAY, K., BO-DENHEIMER, H.C., JR., PERRILLO, R.P., CAREY, W., JACBOSON, I.M., PAYNE, J., DIENSTAG, J.L., VANTHIEL, D.H., TAMBURRO, C., LEFKOWITCH, J., ALBRECHT, J., MESCHEVIEVITZ. C., ORTEGO, T.J., GIBAS, A., and THE HEPATITIS INTERVENTIONAL THERAPY GROUP. (1989). Treatment of chronic hepatitis C with recombinant interferon alfa. N. Engl. J. Med. 321, 1501-1506.
2. SARACCO, G., ROSINA, F., ABATE, M.L., CHIANDUSSI, L., GALLO, V., CERUTTI, E., DI NAPOLI, A., SOLINAS, A., DE-PLANO, A., TOCCO, A., COSSU, P., CHEIN, D., KUO, G., POLITO, A., WEINER, A.J., HOUGHTON, M., VERME, G. BONIMO, F., and RIZZETTO, M. (1993). Long-term follow-ups of patients with chronic hepatitis C treated with different doses of interferon α-2b. Hepatology 18, 1300-1305.
3. TINE, F., MARGIN, S., CRAXI, A., and PAGLIARO, L. (1991). Interferon for chronic non-A, non-B hepatitis: a meta-analysis of randomized clinical trials, J. Hepatol. 13, 192-199.
4. RADWANSKJ, E., PERENTESIS, G., JACOBS, S., ODEN, E., AFFRIME, M., SYMCHOWICZ, S., and ZAMPAGLIONE, N. (1987). Pharmacokinetics of interferon α-2b in healthy volunteers. J. Clin. Pharmacol. 27, 432-435.
5. ANTONELLI, G. (1994). Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy. Antiviral Res. 24, 235-244.
6. IKEDA, Y., TODA, G., HASHIMOTRO, N., UMEDA, N., MIYAKE, K., YAMANAKA, M., and KUROKOWA, K. (1991). Naturally occurring anti-interferon alpha 2a antibodies in patients with acute viral hepatitis. Clin, Exp. Immunol. 85, 80-84.
7. ANTONELLI, G., SIMEOM, E., CURRENTI, M., DE PISA, F., COLIZZI, V., PISTELLO, M., and DIANZANI, F. (1997). interferon antibodies in patients with infectious diseases. Biotherapy 10, 7-14.
8. McKENNA, R.M., and OBERG, K.E. (1997). Antibodies to interferon-α in treated patients: incidence and significance. J. Interferon Cytokine Res. 17, 141-143.
9. GIANELLI, G., ANTONELLI, G., FERA, G., DEL VECCHIO, S., RIVA, E., BROCCIA, C., SCHIRALDI, O., and DIANZANI, F. (1994). Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-α) during therapy for chronic hepatitis C. Clin. Exp. Immunol. 97, 4-9.
10. LOK, A.S.-F., LAI, C.-L., and LEUNG, E.K.-Y. (1990). Interferon antibodies may negate the anti-viral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection. Hepatology 12, 1266-1270.
11. PROTZMAN, W.P., JACOBS, S.L., MINNICOZZI, M., ODEN, E.M., and KELSEY, D.K. (1984). A radioimmunologic technique to screen for antibodies to α-1 interferon. J. Immunol. Methods 75, 317-323.
12. JACOBS, S.J., SULLIVAN, L.M., SALFI, M., GROSSBERG, H., SPIEGEL, R.J., LEIBOWITZ, P.J., ODEN, E.M., KELSEY D.K., and TREUHAFT, M.W. (1988). Minimal antigenicity of Intron A in human recipients demonstrated by three analytical methods. J. Biol. Response Mod. 7, 447-456.
13. JACOBS, S., FRIEDMAN, R.M., NAGABHUSHAN, T.L., ODEN, E., SALFI, M., BORDENS, R., and SPIEGEL, R. (1989). Detection of serum neutralizing antibodies to interferon alfa-2b (Intron A) by means of an enzyme immunoassay. J. Interferon Res. 9 (Suppl. 2), 92.
14. ANTONELLI, G., GIANELLI, G., PISTELLO, M., MAGGI, F., NATTERONI, L., CURRENTI, M., DEL VECCHIO, S., ROFFI, L., PASTORE, G., and DIANZANI, FL. (1984). Clinical significance of recombinant interferon α2 neutralizing antibodies in hepatitis patients. J. Interferon Res. 14, 211-213.
15. VON WUSSOW, P., HEHLMANN, R., HOCHHAUS, T., JAKSCHIES, D., NOLTE, K.U., PRÜMMER, O., ANSARI, H., HASFORD, J., HEIMPEL, H., and DEICHER, H., (1994). Roferon (rIFN-α2aj is more immunogenic than Intron A CrIFN-α2b) in patients with chronic myelogenous leukemia. J. Interferon Res. 14, 217-219.
16. FÄGERSTAM, L.G., FROSTELL-KARLSSON, Å., KARLSSON, R., PERSSON, B., and RÖNNBERG, I. (1992). Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J. Chromatogr. 597,397-410.
17. JÖSSON, U., FÅGERSTAM, L.G., IVARSSON, B., JOHNSSON, B., KARLSSON, R., LUNDH, K., LÖFÄS., S., PERSSON, B., ROOS, H., RÖNNBERG, I., SJÖLANDER, S., STENBERG, E., STÅHLBERG, R., URBANICZKY, C., ÖSTLIN, H., and MALMQVIST, M. (1991). Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology, BioTechniques 11, 620-627.
18. LÖFÄS., S., and JÖHNSSON. B. (1990). A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands. J. Chem. Soc. Chem. Commun. 21, 1526-1528.
19. RAETHER, H. (1977). Surface plasmon oscillations and their applications. In: Physics of Thin Films: Advances in Research and Development. G. Hass (ed.) vol. 9. New York: Academic Press, p. 145.
20. WONG, R.L., MYTYCH, D., JACOBS, S., BORDENS, R., and SWANSON, S.J. (1997). Validation parameters for a novel biosensor assay which measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies. J. Immunol. Methods 209, 1-15.
21. SWANSON, S.J., JACOBS, S.J., MYTYCH, D., SHAH, C., IN-DELICATO, S.R., and BORDENS, R.W. (1999). Applications for the new electrochemiluminescent (ECL) and biosensor technologies. In: Characterization and Assay of Cytokines and Growth Fac- tors. F. Brown and A.R. Mire-Sluis (eds.) Developments in Biological Standardisation, Vol. 97. Basel: Karger,